Day Zero Diagnostics Overview
- Year Founded
-
2016
- Status
-
Acquired/Merged
- Employees
-
56
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$21.6M
Day Zero Diagnostics General Information
Description
Developer of a sequencing-based infectious disease diagnostic system designed for microbiology and molecular labs. The company's system offers an ultra-high enrichment (UHE) capability that is capable of isolating and enriching pathogen deoxyribonucleic acid (DNA) from complex clinical samples, methods for rapid whole genome sequencing (WGS), and computational pipelines that can perform clinical-grade organism identification and antibiotic susceptibility profiling, enabling microbiology and molecular labs to perform organism identity (ID) and antibiotic susceptibility testing directly from clinical samples.
Contact Information
Website
www.dayzerodiagnostics.comCorporate Office
- 250 Arsenal Place
- Suite 320
- Watertown, MA 02472
- United States
Corporate Office
- 250 Arsenal Place
- Suite 320
- Watertown, MA 02472
- United States
Day Zero Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. Merger/Acquisition | 13-Jun-2025 | $21.6M | Completed | Generating Revenue | ||
| 19. Later Stage VC (Series B) | 30-Aug-2023 | Completed | Generating Revenue | |||
| 18. Grant | 08-Aug-2023 | Completed | Generating Revenue | |||
| 17. Grant | 20-Oct-2022 | Completed | Generating Revenue | |||
| 16. Grant | 01-Jun-2022 | Completed | Generating Revenue | |||
| 15. Later Stage VC (Series A1) | 09-Feb-2022 | Completed | Generating Revenue | |||
| 14. Grant | 01-May-2020 | Completed | Generating Revenue | |||
| 13. Grant | 11-Jul-2019 | Completed | Generating Revenue | |||
| 12. Grant | 11-Jul-2019 | $224K | $13.1M | Completed | Generating Revenue | |
| 11. Early Stage VC (Series A) | 20-Dec-2018 | $8.57M | $13.1M | Completed | Generating Revenue |
Day Zero Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed | 5,394,000 | $0.000100 | $0.03 | $0.68 | $0.68 | 1x | $0.68 | 11.98% |
Day Zero Diagnostics Comparisons
Industry
Financing
Details
Day Zero Diagnostics Competitors (7)
One of Day Zero Diagnostics’s 7 competitors is Karius, a Venture Capital-Backed company based in Redwood City, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Karius | Venture Capital-Backed | Redwood City, CA | ||||
| Inflammatix | Venture Capital-Backed | Sunnyvale, CA | ||||
| Synthecon | Formerly Accelerator/Incubator backed | Houston, TX | ||||
| Prellis Biologics | Venture Capital-Backed | Berkeley, CA | ||||
| Pattern (Discovery Tools) | Venture Capital-Backed | Austin, TX |
Day Zero Diagnostics Patents
Day Zero Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025136913-A1 | Split sample processing | Inactive | 18-Dec-2023 | ||
| WO-2025117627-A1 | Internal process control | Inactive | 01-Dec-2023 | ||
| WO-2025111453-A1 | Sps mitigation | Inactive | 22-Nov-2023 | ||
| WO-2022164968-A1 | Methods for enriching microorganisms from low abundance clinical samples for dna sequencing | Inactive | 29-Jan-2021 | ||
| WO-2022115318-A1 | Universal primers for rapid bacterial genome detection | Inactive | 24-Nov-2020 | C12Q1/689 |
Day Zero Diagnostics Signals
Day Zero Diagnostics Former Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Becton, Dickinson and Company | Corporation | Minority | ||
| CARB-X | University | |||
| Golden Seeds | Venture Capital | Minority | ||
| Golden Seeds Ventures | Venture Capital | Minority | ||
| HTA (Little Rock) | Accelerator/Incubator | Minority |
Day Zero Diagnostics FAQs
-
When was Day Zero Diagnostics founded?
Day Zero Diagnostics was founded in 2016.
-
Where is Day Zero Diagnostics headquartered?
Day Zero Diagnostics is headquartered in Watertown, MA.
-
What is the size of Day Zero Diagnostics?
Day Zero Diagnostics has 56 total employees.
-
What industry is Day Zero Diagnostics in?
Day Zero Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Day Zero Diagnostics a private or public company?
Day Zero Diagnostics is a Private company.
-
What is the current valuation of Day Zero Diagnostics?
The current valuation of Day Zero Diagnostics is .
-
What is Day Zero Diagnostics’s current revenue?
The current revenue for Day Zero Diagnostics is .
-
How much funding has Day Zero Diagnostics raised over time?
Day Zero Diagnostics has raised $50.1M.
-
Who are Day Zero Diagnostics’s investors?
Becton, Dickinson and Company, CARB-X, Golden Seeds, Golden Seeds Ventures, and HTA (Little Rock) are 5 of 18 investors who have invested in Day Zero Diagnostics.
-
Who are Day Zero Diagnostics’s competitors?
Karius, Inflammatix, Synthecon, Prellis Biologics, and Pattern (Discovery Tools) are some of the 7 competitors of Day Zero Diagnostics.
-
When was Day Zero Diagnostics acquired?
Day Zero Diagnostics was acquired on 13-Jun-2025.
-
Who acquired Day Zero Diagnostics?
Day Zero Diagnostics was acquired by BioMérieux.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process